2395 — Shin Nippon Biomedical Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Shin Nippon Biomedical Laboratories, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	7,287	6,997	10,533	10,611	12,032
Net Total Accounts Receivable
Net Total Receivables	2,952	3,499	4,694	5,723	6,512
Total Inventory
Total Other Current Assets
Total Current Assets	14,780	16,134	23,900	30,838	32,940
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12,898	13,156	18,879	26,358	34,833
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	36,972	39,313	57,242	76,302	92,417
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11,916	13,374	21,012	23,568	29,256
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	21,238	19,752	31,030	42,188	52,394
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	15,734	19,561	26,212	34,114	40,023
Total Liabilities & Shareholders' Equity	36,972	39,313	57,242	76,302	92,417
Total Common Shares Outstanding